Artiva Biotherapeutics

Artiva Biotherapeutics

NK cell therapy for cancer patients. Learn more

Launch date
Employees
Market cap
€220m
Enterprise valuation
€192m (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...